BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33028080)

  • 21. The mechanism research on the anti-liver fibrosis of emodin based on network pharmacology.
    Liang B; Gao L; Wang F; Li Z; Li Y; Tan S; Chen A; Shao J; Zhang Z; Sun L; Zhang F; Zheng S
    IUBMB Life; 2021 Sep; 73(9):1166-1179. PubMed ID: 34173707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGFBPrP1 induces liver fibrosis by inducing hepatic stellate cell activation and hepatocyte apoptosis via Smad2/3 signaling.
    Zhang Y; Zhang QQ; Guo XH; Zhang HY; Liu LX
    World J Gastroenterol; 2014 Jun; 20(21):6523-33. PubMed ID: 24914373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cordycepin alleviates hepatic fibrosis in association with the inhibition of glutaminolysis to promote hepatic stellate cell senescence.
    Liang Z; Zhang K; Guo H; Tang X; Chen M; Shi J; Yang J
    Int Immunopharmacol; 2024 May; 132():111981. PubMed ID: 38565039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice.
    Kong X; Feng D; Wang H; Hong F; Bertola A; Wang FS; Gao B
    Hepatology; 2012 Sep; 56(3):1150-9. PubMed ID: 22473749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
    Wang L; Zhang Z; Li M; Wang F; Jia Y; Zhang F; Shao J; Chen A; Zheng S
    IUBMB Life; 2019 Jan; 71(1):45-56. PubMed ID: 30321484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts.
    Kim KH; Chen CC; Monzon RI; Lau LF
    Mol Cell Biol; 2013 May; 33(10):2078-90. PubMed ID: 23508104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
    Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrodynamics-based transfection of rat interleukin-10 gene attenuates porcine serum-induced liver fibrosis in rats by inhibiting the activation of hepatic stellate cells.
    Huang YH; Chen YX; Zhang LJ; Chen ZX; Wang XZ
    Int J Mol Med; 2014 Sep; 34(3):677-86. PubMed ID: 24993843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis.
    Liu Y; Yang P; Chen N; Lin S; Liu M
    Int J Mol Med; 2016 Oct; 38(4):1093-100. PubMed ID: 27572658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis.
    Kocabayoglu P; Lade A; Lee YA; Dragomir AC; Sun X; Fiel MI; Thung S; Aloman C; Soriano P; Hoshida Y; Friedman SL
    J Hepatol; 2015 Jul; 63(1):141-7. PubMed ID: 25678385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.
    Tseng TH; Lin WL; Chen ZH; Lee YJ; Shie MS; Lee KF; Shen CH; Kuo HC
    J Transl Med; 2016 Sep; 14(1):263. PubMed ID: 27612633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
    Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
    Hu YB; Ye XT; Zhou QQ; Fu RQ
    Cell Physiol Biochem; 2018; 51(5):2111-2122. PubMed ID: 30522100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnesium isoglycyrrhizinate promotes the activated hepatic stellate cells apoptosis via endoplasmic reticulum stress and ameliorates fibrogenesis in vitro and in vivo.
    Bian M; Chen X; Zhang C; Jin H; Wang F; Shao J; Chen A; Zhang F; Zheng S
    Biofactors; 2017 Nov; 43(6):836-846. PubMed ID: 29048780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells.
    Kumar P; Smith T; Raeman R; Chopyk DM; Brink H; Liu Y; Sulchek T; Anania FA
    J Biol Chem; 2018 Aug; 293(33):12781-12792. PubMed ID: 29941453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The flavonoid GL-V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells.
    Zhao J; Bai D; Qi L; Cao W; Du J; Gu C; Zhou C; Gao Y; Zhang L; Zhao Y; Lu N
    Br J Pharmacol; 2023 Apr; 180(8):1072-1089. PubMed ID: 36455594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells.
    Shi Z; Zhang K; Chen T; Zhang Y; Du X; Zhao Y; Shao S; Zheng L; Han T; Hong W
    Cell Death Dis; 2020 Dec; 11(12):1066. PubMed ID: 33311456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
    de Oliveira da Silva B; Ramos LF; Moraes KCM
    Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
    Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
    FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.